SAN DIEGO: Alterome Therapeutics, Inc., a trailblazer in the biopharmaceutical industry, has successfully completed a Series B financing round, raising a substantial $132 million. This funding marks a pivotal step for the company as it aims to transition multiple innovative cancer treatments from the laboratory to clinical trials. “We are pleased with a financing of…